The US Food and Drug Administration (FDA) has approved Neurelis’ diazepam nasal spray, Valtoco, for the short-term treatment ...

California follows a 'Harm Reduction' model for drug users, focusing on minimizing overdoses instead of stopping drug use ...

Decongestant sprays shouldn't be used for more than a week - but those who don't realise can become trapped in a cycle of ...

In the latest maneuver in the battle against opioid deaths in California, Gov. Gavin Newsom announced Monday that all ...

Naloxone, which can reverse overdoses of opioids, has been available in the U.S. without a prescription since March of 2023, ...

Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved VALTOCO® (diazepam nasal spray) for short-term treatment of seizure clusters (also known as "acute repetitive ...

Polyrizon (PLRZ) announced the preliminary safety study for a formulation of its PL-14 Allergy Blocker. Conducted on fully differentiated human ...

The US Food and Drug Administration (FDA) has approved Neurelis’ diazepam nasal spray, Valtoco, for the short-term treatment of acute repetitive seizures, also referred to as seizure clusters ...